| Issue |
Title |
| Vol 79, No 5 (2004) |
Immune system in patients with metabolic syndrome |
|
|
Zabelina V.D., Zemskov V.M., Mkrtumyan A.M., Balabolkin M.I., Antonova O.A. |
| Vol 82, No 6 (2010) |
Association of obstructive sleep apnea syndrome with the signs of non-alcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome |
|
|
Severova M.M., Fomin V.V., Lebedeva M.V., Sorokin Y.D., Saginova E.A., Minakova E.G., Gallyamov M.G., Mukhin N.A. |
| Vol 84, No 6 (2012) |
CLINICOPATHOGENETIC CHARACTERISTICS OF CARDIORENAL SYNDROME IN NON-ALCOHOLIC FATTY DISEASE OF THE LIVER |
|
|
Severova M.M., Saginova E.A., Gallyamov M.G., Ermakov N.V., Rodina A.V., Fomin V.V., Mukhin N.A. |
| Vol 91, No 2 (2019) |
Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease |
|
|
Akhmedov V.A., Gaus O.V. |
| Vol 91, No 9 (2019) |
Epicardial adipose tissue as a marker of visceral obesity and its association with metabolic parameters and remodeling of the left chambers of the heart in young people with abdominal obesity |
|
|
Blinova N.V., Azimova M.O., Zhernakova Y.V., Zheleznova E.A., Yarovaya E.B., Orlovskiy A.A., Azimova M.R., Dobrovolskaya S.V., Ternovoy S.K., Chazova I.E. |
| Vol 90, No 8 (2018) |
Inhibition of HIF-prolyl 4-hydroxylases as a promising approach to the therapy of cardiometabolic diseases |
|
|
Aitbaev K.A., Murkamilov I.T., Fomin V.V. |
| Vol 87, No 5 (2015) |
Evaluation of endothelial function and estimation of the degree of apoptosis in patients with metabolic syndrome and non-alcoholic fatty liver disease |
|
|
Drapkina O.M., Deeva T.A., Ivashkin V.T. |
| Vol 82, No 10 (2010) |
Metabolic syndrome and insulin resistance in patients with chronic hepatitis C |
|
|
Bayzhanova Z.Z., Ignatova T.M., Nekrasova T.P., Baizhanova Z.Z., Ignatova T.M., Nekrasova T.P. |
| Vol 79, No 10 (2004) |
Metabolic syndrome of insulin resistance: basic conception and consequences (a review) |
|
|
Starkova N.Т., Dvoryashina I.V. |
| Vol 88, No 3 (2016) |
Population characteristics of metabolic syndrome components in 25—64-year-old males of an average urbanized Siberian town |
|
|
Akimova E.V., Kayumov R.K., Gakova E.I., Zagorodnykh E.Y., Gafarov V.V., Kuznetsov V.A. |
| Vol 84, No 12 (2012) |
Quality of life in patients with coronary heart disease associated with metabolic syndrome: Results of factor analysis |
|
|
Kaliuzhin V.V., Tepliakov A.T., Riazantseva N.V., Bespalova I.D., Kamaev D.I., Kaliuzhina E.V. |
| Vol 90, No 1 (2018) |
Stress in the family - association with prevalence of cardiovascular diseases in men of the open city population |
|
|
Akimova E.V., Akimov M.J., Gakova E.I., Kayumova M.M., Gafarov V.V., Kuznetsov V.A. |
| Vol 87, No 1 (2015) |
Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: Possibility for correction and prevention |
|
|
Shishkova V.N. |
| Vol 82, No 10 (2010) |
Chronic cerebrovascular diseases, metabolic syndrome, and the hemorrheological and hemostatic systems |
|
|
Tanashyan M.M., Ionova V.G., Orlov S.V., Omel'chenko N.G., Shabalina A.A., Kostyreva M.V., Tanashyan M.M., Ionova V.G., Orlov S.V., Omelchenko N.G., Shabalina A.A., Kostyreva M.V. |
| Vol 89, No 1 (2017) |
Involvement of the hepatobiliary system and pancreas in obesity |
|
|
Akhmedov V.A., Gaus O.V. |
| Vol 85, No 12 (2013) |
Relationships between serum lipid composition and acetylator status as markers of energy metabolism in women with coronary heart disease, metabolic syndrome, and type 2 diabetes mellitus |
|
|
Matveeva S.A. |
| Vol 79, No 6 (2004) |
Cerebrovascular complications in metabolic syndrome: possible approaches to a lower risk |
|
|
Chazova I.E., Mychka V.В., Mamyrbaeva К.М., Gornostaev V.V., Dvoskina I.M., Sergienko V.B. |
| Vol 91, No 10 (2019) |
Abnormal values of trace elements and blood metals in patients with metabolic syndrome, depending on its components |
|
|
Podzolkov V.I., Korolyova T.V., Kudryavtseva M.G. |
| Vol 88, No 2 (2016) |
Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome |
|
|
Drapkina O.M., Zyatenkova E.V. |
| Vol 84, No 9 (2012) |
Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-γ2 gene polymorphism |
|
|
Lavrenko A.V., Shlykova O.A., Kutsenko L.A., Mamontova T.V., Kaĭdashev I.P. |
| Vol 88, No 10 (2016) |
Obesity in metabolic syndrome, as well as kidney dysfunction |
|
|
Sadulaeva I.A., Vasyuk Y.A., Trofimenko O.S., Yushchuk E.N., Ivanova S.V., Shupenina E.Y., Nesterova E.A. |
| Vol 86, No 10 (2014) |
Current approaches to diagnosing and treating nonalcoholic fatty liver disease |
|
|
Drapkina O.M., Deeva T.A., Volkova N.P., Ivashkin V.T. |
| Vol 82, No 6 (2010) |
Autonomic imbalance in patients with metabolic syndrome: role in the development of hyperfiltration, an early marker of renal lesion |
|
|
Gornostayeva E.Y., Novikova M.S., Beloborodova A.V., Akarachkova E.S., Shilov E.M., Shvarkov S.B. |
| Vol 89, No 1 (2017) |
Chronic obstructive pulmonary disease concurrent with metabolic syndrome: Pathophysiological and clinical features |
|
|
Budnevsky A.V., Ovsyannikov E.S., Labzhania N.B. |
| Vol 85, No 10 (2013) |
Cerebrovascular diseases and metabolic syndrome |
|
|
Tanashian M.M., Lagoda O.V., Orlov S.V., Telenkova N.G., Maksiutkina L.N., Petrukhina S.I. |
| Vol 91, No 11 (2019) |
The value of mucosal small intestine microbiota in digestion and absorption disorders in metabolic syndrome |
|
|
Lyapina M.V., Vakhrushev Y.M. |
| Vol 87, No 10 (2015) |
Asthma and metabolic syndrome: Clinical and pathogenetic relationships |
|
|
Budnevsky A.V., Malysh E.Y., Ovsyannikov E.S., Drobysheva E.S. |
| Vol 84, No 6 (2012) |
REMODELING OF CARDIOVASCULAR SYSTEM AND DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME AND OBESITY: ROLE OF GENES ENOS, SUBUNIT P22-PHOX OF NADPH-OXIDASE AND MTHFR |
|
|
Saginova E.A., Gallyamov M.G., Balatsky A.V., Kolotvin A.V., Severova M.V., Samokhodskaya L.M., Fomin V.V., Krasnova T.N., Mukhin N.A. |
| Vol 88, No 10 (2016) |
Prevalence of metabolic syndrome in 25—45-year-old Novosibirsk dwellers |
|
|
Voevoda M.I., Kovalkova N.A., Ragino Y.I., Travnikova N.Y., Denisova D.V. |
| Vol 89, No 4 (2017) |
Chronic constipation in the practice of a therapist: Features of therapy for comorbidity |
|
|
Svistunov A.A., Osadchuk M.A., Butorova L.I., Tokmulina G.M. |
| Vol 85, No 10 (2013) |
Prothrombotic state in patients with metabolic syndrome: an association with inflammation |
|
|
Kaliuzhin V.V., Sibireva O.F., Bespalova I.D., Kaliuzhina E.V., Tkalich L.M., Milovanova T.A., Osikhov I.A., Murashev B.I. |
| Vol 79, No 1 (2004) |
A comprehensive assessment of metabolic parameters in obese patients on xenical |
|
|
Ametov A.S., Demidova T.Y., Tselikovskaya A.L. |
| Vol 91, No 5 (2019) |
Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy |
|
|
Eliseev M.S., Novikova A.M. |
| Vol 90, No 4 (2018) |
A new look at dietary fibers in metabolic syndrome |
|
|
Onuchina E.V. |
| Vol 86, No 12 (2014) |
Associations of the prevalence of cardiovascular diseases with a high level of depression in the open population of an average urbanized Siberian town |
|
|
Akimova E.V., Kuznetsov V.A., Kaiumova M.M., Gafarov V.V., Kaiumov R.K., Gakova E.I., Smaznov V.I. |
| Vol 89, No 5 (2017) |
Clinical features of osteoarthritis in patients with metabolic syndrome |
|
|
Vasilyeva L.V., Lakhin D.I. |
| Vol 85, No 5 (2013) |
Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome |
|
|
Kaliuzhin V.V., Tepliakov A.T., Pushnikova E.I., Bespalova I.D., Kaliuzhina E.V., Kolesnikov R.N. |
| Vol 78, No 12 (2003) |
Role of polymorphism of angiotensinconverting enzyme gene in development of metabolic syndrome |
|
|
Roitberg G.E., Tikhonravov A.V., Dorosh Z.V. |
| Vol 87, No 10 (2015) |
Motor-evacuatory function of the gastrointestinal tract in metabolic syndrome |
|
|
Vakhrushev Y.M., Lyapina M.V. |
| Vol 84, No 2 (2012) |
Specific dynamic action of food in patients with chronic pancreatitis accompanied with metabolic syndrome |
|
|
Vakhrushev Y.M., Volkova A.A., Vakhrushev Y.M., Volkova A.A. |
| Vol 89, No 10 (2017) |
New aspects of Helicobacter pylori infection: Association with metabolic disturbances |
|
|
German S.V., Bobrovnitsky I.P. |
| Vol 86, No 8 (2014) |
Efficacy of metformin in abdominal obesity |
|
|
Mkrtumian A.M., Markova T.N., Kichigin V.A., Podachina S.V., Zhuchkova S.M. |
| Vol 82, No 4 (2010) |
Hyperfiltration is an early sign of evolving chronic renal disease in males with metabolic syndrome |
|
|
Novikova M.S., Shilov E.M., Borisov V.V., Novikova M.S., Shilov E.M., Borisov V.V. |
| Vol 88, No 9 (2016) |
Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora |
|
|
Drapkina O.M., Korneeva O.N. |
| Vol 85, No 4 (2013) |
Metabolic correction of dyslipidemia in patients with nonalcoholic fatty liver disease as a new therapy policy |
|
|
Stel'makh V.V., Kozlov V.K. |
| Vol 78, No 10 (2003) |
A lipid profile of blood plasm inpatients with metabolic syndrome and manifest disorder ofcarbohydrate metabolism |
|
|
Medvedeva I.V., Dorodneva E.F., Pugacheva T.A., Bekhikova L.N., Zhuravleva T.D. |
| No 1 (2009) |
Effects of metabolic syndrome on the phenomenon of electrophysiological atrioventricular conduction curve gap in the course of programmed transesophageal pacing |
|
|
Provotorov V.M., Glukhovskiy M.L., Provotorov V.M., Glukhovsky M.L. |
| Vol 87, No 10 (2015) |
Association of adiponectin gene G276T polymorphism with the development of metabolic syndrome in ethnic Kyrgyz patients |
|
|
Isakova J.T., Lunegova O.S., Talaibekova E.T., Asambaeva D.A., Kerimkulova A.S., Aldashev A.A. |
| Vol 83, No 10 (2011) |
Lozartan potential in hyperuricemia correction |
|
|
Nedogoda S.V., Nedogoda S.V. |
| Vol 86, No 8 (2014) |
Clinical features of chronic hepatitis B in the presence of metabolic syndrome and insulin resistance |
|
|
Tkachenko L.I., Maleev V.V. |
| Vol 81, No 6 (2009) |
Affection of target organs in hypertensive patients with and without metabolic syndrome |
|
|
Sharipova G.K., Saidova M.A., Balakhonova T.V., Mychka V.B., Chazova I.E., Sharipova G.K., Saidova M.A., Balakhonova T.V., Mychka V.B., Chazova I.E. |
| Vol 88, No 9 (2016) |
Nonalcoholic steatohepatitis and biliary sludge in people with metabolic syndrome |
|
|
Radchenko V.G., Seliverstov P.V., Ledentsova S.S., Manyakov A.V. |
| Vol 78, No 3 (2003) |
Pathogenesis of arterial hypertension within the metabolic syndrome |
|
|
Ryazanov A.S., Arakelyants A.A., Yurenev A.P. |
| Vol 83, No 10 (2011) |
Low-dose combination of perindopril arginine with indapamide in correction of metabolic syndrome |
|
|
Kseneva S.I., Borodulina E.V., Semiglazova T.A., Kulakova N.V., Tarasova I.V., Udut V.V., Kseneva S.I., Borodulina E.V., Semiglazova T.A., Kulakova N.V., Tarasova I.V., Udut V.V. |
| Vol 89, No 10 (2017) |
Enteral failure and metabolic syndrome: Common neurohormonal mechanisms of development, possibilities of their rational therapy |
|
|
Vakhrushev Y.M., Lyapina M.V. |
| Vol 81, No 4 (2009) |
The role of thyroid hypofunction in development of metabolic syndrome |
|
|
Demidova T.Y., Galieva O.R., Demidova T.Y., Galieva O.R. |
| Vol 85, No 1 (2013) |
The clinical efficacy of a succinate-containing infusion drug during pharmacotherapy for hepatic lesions of varying genesis: results of meta-analysis |
|
|
Mazina N.K., Mazin P.V., Sukhanov D.S. |
| Vol 91, No 2 (2019) |
Vitamins in diet of patients with metabolic syndrome |
|
|
Kodentsova V.M., Risnik D.V., Sharafetdinov K.K., Nikityuk D.B. |
| Vol 83, No 10 (2011) |
Taurin in combined treatment of metabolic syndrome and diabetes mellitus |
|
|
Ametov A.S., Kochergina I.I., Doskina E.V., Abaeva B.S., Elizarova E.P., Ametov A.S., Kochergina I.I., Doskina E.V., Abaeva B.S., Elizarova E.P. |
| Vol 89, No 10 (2017) |
Associations between metabolic syndrome and reduced lung function in young people |
|
|
Kovalkova N.A., Ragino Y.I., Travnikova N.Y., Denisova D.V., Shcherbakova L.V., Voevoda M.I. |
| Vol 86, No 5 (2014) |
Hormonal aspects of the development of obesity and metabolic syndrome in ethnic groups (by the population of the Chuvash Republic) |
|
|
Markova T.N., Kichigin V.A., Madianov I.V., Semakina S.M., Diomidova V.N. |
| Vol 80, No 12 (2008) |
Clinico-immunological disorders in patients with ischemic heart disease and metabolic syndrome: correction with nebivolol |
|
|
Teplyakov A.T., Bolotskaya L.A., Vdovina T.V., Stepacheva T.A., Kuznetsova A.V., Teplyakov A.T., Bolotskaya L.A., Vdovina T.V., Stepacheva T.A., Kuznetsova A.V. |
| Vol 88, No 8 (2016) |
Blood fatty acids in the development and correction of metabolic syndrome |
|
|
Novgorodtseva T.P., Denisenko Y.K., Antonyuk M.V., Yubitskaya N.S., Lobanova E.G., Zhukova N.V. |
| Vol 84, No 10 (2012) |
Melatonin and metabolic syndrome: Is there their association? |
|
|
Dzherieva I.S., Volkova N.I., Rapoport S.I. |
| Vol 90, No 10 (2018) |
The prevalence of components of metabolic syndrome in the patients with diabetes melitus type 2 and mody diabetes in young people of Novosibirsk |
|
|
Mustafina S.V., Ovsyannikova A.K., Voevoda M.I., Denisova D.V., Sherbakova L.V., Rymar O.D. |
| Vol 83, No 8 (2011) |
The role of lipid disbolism in kidney disease in metabolic syndrome associated with obesity |
|
|
Kryachkova A.A., Savel'eva S.A., Kutyrina I.M., Kryachkova A.A., Savelyeva S.A., Kutyrina I.M. |
| Vol 79, No 12 (2004) |
The role of hypersympathycotony in development of arterial hypertensionin patients with metabolic syndrome: potential of pathogenetically sound therapy |
|
|
Ametov A.S., Demidova T.Y., Smagina L.V. |
| Vol 84, No 12 (2012) |
The role of the small intestine in the development of metabolic syndrome |
|
|
Vakhrushev I.M., Liapina M.V. |
| Vol 90, No 11 (2018) |
The role of systemic inflammation in the pathogenesis of insulin resistance and metabolic syndrome in patients with chronic hepatitis C |
|
|
Tkachenko L.I., Maleev V.V. |
| Vol 89, No 8 (2017) |
Correction of small bowel function as a new direction for treating patients with metabolic syndrome |
|
|
Vakhrushev Y.M., Lyapina M.V. |
| Vol 79, No 11 (2004) |
Arterial hypertension in adolescents with different physical constitution including those with signs of metabolic syndrome |
|
|
Rovda Y.I., Kazakova L.M., Rovda T.S., Rovda E.Y. |
| Vol 88, No 8 (2016) |
Pulmonary rehabilitation as an effective method for optimizing therapeutic and preventive measures in patients with chronic obstructive pulmonary disease concurrent with metabolic syndrome |
|
|
Budnevsky A.V., Isaeva Y.V., Malysh E.Y., Kozhevnikova S.A. |
| 1 - 72 of 72 Items |
|
